MGMT-Unmethylated Glioblastoma — Trials

MGMT-Unmethylated Glioblastoma — Trials · CancerIndex

Clinical trials

Registered studies

19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 7
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Northwestern University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03107780	Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer	terminated	Phase 1	32	National Cancer Institute (NCI)NIH	1	Nov 13, 2025	clinicaltrials
NCT03250299	Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma	terminated	Phase 1	26	Basilea PharmaceuticaINDUSTRY	1	Jun 24, 2024	clinicaltrials